Agenus Inc. (NASDAQ:AGEN) Q4 2023 Earnings Call Transcript
Agenus Inc. misses on earnings expectations. Reported EPS is $-0.13 EPS, expectations were $-0.053.
Agenus Inc (AGEN)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Deep Track Capital David Kroin | 1,584,876.95 | $26,242,393 | 0.87% | |
| 2. | Point72 Asset Management Steve Cohen | 599,260 | $9,922,547 | -32% | 0.02% |
| 3. | Millennium Management Israel Englander | 419,147.55 | $6,940,245 | +571% | 0% |
| 4. | D E Shaw D. E. Shaw | 152,006.55 | $2,516,924 | 0% | |
| 5. | Citadel Investment Group Ken Griffin | 54,122.95 | $896,167 | +2276% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.65 | 500,000 | 625,969 | 2024-02-15 | Filing | ||
| $0.76 | 25,000 | 124,063 | 2023-11-15 | Filing | ||
| $3.61 | 40,388 | Officer | 1,590,441 | 2017-10-30 | Filing | |
| $3.51 | 59,612 | Officer | 1,550,053 | 2017-10-27 | Filing | |
| $3.29 | 29,456 | Officer, Director | 1,418,477 | 2017-04-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.06 | 38,679 | Officer | 61,321 | 2022-01-06 | Filing | |
| $6.50 | 82,107 | Officer, Director | 770,773 | 2021-09-13 | Filing | |
| $6.50 | 11,120 | Officer | 93,056 | 2021-09-10 | Filing | |
| $3.66 | 141,920 | Large Shareholder | 16,972,968 | 2020-06-17 | Filing | |
| $3.66 | 72,080 | Large Shareholder | 17,114,888 | 2020-06-16 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,611,824.4 | $26,688,588 | 0% | |
| 2. | 1,513,344.5 | $25,057,958 | 0% | |
| 3. | 782,811.7 | $12,961,796 | 0.72% | |
| 4. | 434,013.35 | $7,186,393 | 0% | |
| 5. | 395,378.05 | $6,547,337 | 0% |
News See All
Agenus Inc. (NASDAQ:AGEN) Q1 2023 Earnings Call Transcript
Operator: Good day, and welcome to the Agenus First Quarter 2023 Financial Results Conference Call. All lines have been placed on mute to prevent any background noise.
Agenus Inc. (NASDAQ:AGEN) Q4 2022 Earnings Call Transcript
Operator: Thank you for holding and welcome, everyone, to the Agenus Fourth Quarter and Full Year 2022 Financial Results Conference Call.
12 Best Biotech Stocks to Buy Under $10
The past two years have been challenging for the biotech sector, based on the market performance of biotech equities. Compared to larger stock market indexes, biotechnology indices underperformed.
5 Best Biotech Stocks Under $5
Agenus Inc. (NASDAQ:AGEN) is a clinical-stage immuno-oncology company based in Lexington, Massachusetts.
5 Best Stocks for Long Term Growth
Sundial Growers Inc. (NASDAQ: SNDL) is a firm that makes and sells cannabis products. Its dried flower cannabis products are available in a variety of formats, including pre-rolls, oils and capsules.
5 Biotech Stocks Popular On Reddit
Agenus Inc. (NASDAQ: AGEN) ranks 5th on the list of 11 biotech stocks popular on Reddit. The Massachusetts-based biotech firm develops immuno-oncology therapeutics.
Is AGEN A Good Stock To Buy Now?
The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive database.
Hedge Fund and Insider Trading News: Bill Ackman, Anthony Scaramucci, Michael Hintze, Steve Cohen, Silver Lake Partners, Guardant Health Inc (GH), JMP Group LLC (JMP), and More
Michael Hintze should find a way to focus on trading again. After all, CQS once boasted returns that were triple the hedge fund industry average.
Is Agenus Inc (AGEN) A Good Stock To Buy?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).